,0
zip,07302
sector,Healthcare
fullTimeEmployees,9300
longBusinessSummary,"Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey."
city,Jersey City
phone,551 430 6000
state,NJ
country,United States
companyOfficers,[]
website,https://www.organon.com
maxAge,1
address1,30 Hudson Street
industry,Drug Manufacturersâ€”General
address2,Floor 33
ebitdaMargins,0.31916
profitMargins,0.21430999
grossMargins,0.62325
operatingCashflow,2457999872
revenueGrowth,-0.006
operatingMargins,0.28823
ebitda,2012000000
targetLowPrice,37
recommendationKey,buy
grossProfits,3929000000
freeCashflow,2661374976
targetMedianPrice,40
currentPrice,34.99
earningsGrowth,-0.453
currentRatio,1.448
returnOnAssets,0.10925
numberOfAnalystOpinions,7
targetMeanPrice,40
debtToEquity,
returnOnEquity,0.67924005
targetHighPrice,44
totalCash,737000000
totalDebt,9363999744
totalRevenue,6304000000
totalCashPerShare,2.906
financialCurrency,USD
revenuePerShare,24.864
quickRatio,0.866
recommendationMean,2.4
exchange,NYQ
shortName,Organon & Co.
longName,Organon & Co.
exchangeTimezoneName,America/New_York
exchangeTimezoneShortName,EDT
isEsgPopulated,False
gmtOffSetMilliseconds,-14400000
underlyingSymbol,
quoteType,EQUITY
symbol,OGN
underlyingExchangeSymbol,
headSymbol,
messageBoardId,finmb_653748561
uuid,1bf1386a-e8ec-3070-9c74-cd495b950fc0
market,us_market
annualHoldingsTurnover,
enterpriseToRevenue,2.776
beta3Year,
enterpriseToEbitda,8.699
52WeekChange,0.05233085
morningStarRiskRating,
forwardEps,5.73
revenueQuarterlyGrowth,
sharesOutstanding,253636992
fundInceptionDate,
annualReportExpenseRatio,
totalAssets,
bookValue,-5.948
sharesShort,5887123
sharesPercentSharesOut,0.0232
fundFamily,
lastFiscalYearEnd,1640908800
heldPercentInstitutions,0.73195
netIncomeToCommon,1351000064
trailingEps,5.31
lastDividendValue,0.28
SandP52WeekChange,0.14403355
priceToBook,
heldPercentInsiders,0.00032000002
nextFiscalYearEnd,1703980800
yield,
mostRecentQuarter,1640908800
shortRatio,1.98
sharesShortPreviousMonthDate,1644883200
floatShares,253469778
beta,
enterpriseValue,17501765632
priceHint,2
threeYearAverageReturn,
lastSplitDate,
lastSplitFactor,
legalType,
lastDividendDate,1645747200
morningStarOverallRating,
earningsQuarterlyGrowth,-0.451
priceToSalesTrailing12Months,1.407798
dateShortInterest,1647302400
pegRatio,-1.28
ytdReturn,
forwardPE,6.1064577
lastCapGain,
shortPercentOfFloat,
sharesShortPriorMonth,4936031
impliedSharesOutstanding,0
category,
fiveYearAverageReturn,
previousClose,35.3
regularMarketOpen,35.45
twoHundredDayAverage,32.6766
trailingAnnualDividendYield,0.015864024
payoutRatio,0.105500005
volume24Hr,
regularMarketDayHigh,35.725
navPrice,
averageDailyVolume10Day,3312410
regularMarketPreviousClose,35.3
fiftyDayAverage,34.4746
trailingAnnualDividendRate,0.56
open,35.45
toCurrency,
averageVolume10days,3312410
expireDate,
algorithm,
dividendRate,1.12
exDividendDate,1645747200
circulatingSupply,
startDate,
regularMarketDayLow,34.79
currency,USD
trailingPE,6.589454
regularMarketVolume,1060281
lastMarket,
maxSupply,
openInterest,
marketCap,8874759168
volumeAllCurrencies,
strikePrice,
averageVolume,2295501
dayLow,34.79
ask,35.22
askSize,900
volume,1060281
fiftyTwoWeekHigh,39.475
fromCurrency,
fiveYearAvgDividendYield,
fiftyTwoWeekLow,27.25
bid,34.8
tradeable,False
dividendYield,0.0317
bidSize,1200
dayHigh,35.725
regularMarketPrice,34.99
preMarketPrice,34.8
logo_url,https://logo.clearbit.com/organon.com
